Page 850 - Read Online

Page 12 of 12 Favre et al. Plast Aesthet Res 2020;7:71 I http://dx.doi.org/10.20517/2347-9264.2020.149

neuromodulators and soft tissue fillers. Plast Reconstr Surg Glob Open 2016;4:e1175.
14. Scheinfeld N. The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face. Dermatol
Online J 2005;11:9.
15. Fabi SG, Sundaram H, Guiha I, Goldman MP. A two-center, open-label, randomized, split-face study to assess the efficacy and safety
of one versus three intradermal injection sites of abobotulinumtoxinA in the treatment of lateral periocular rhytides. J Drugs Dermatol
2013;12:932-7.
16. Carruthers J, Carruthers A. Aesthetic botulinum A toxin in the mid and lower face and neck. Dermatol Surg 2003;29:468-76.
17. Loos BM, Maas CS. Relevant anatomy for botulinum toxin facial rejuvenation. Facial Plast Surg Clin North Am 2003;11:439-43.
18. Suber JS, Dinh TP, Prince MD, Smith PD. OnabotulinumtoxinA for the treatment of a “gummy smile”. Aesthet Surg J 2014;34:432-7.
19. Sucupira E, Abramovitz A. A simplified method for smile enhancement: botulinum toxin injection for gummy smile. Plast Reconstr Surg
2012;130:726-8.
20. Choi YJ, Kim JS, Gil YC, et al. Anatomical considerations regarding the location and boundary of the depressor anguli oris muscle with
reference to botulinum toxin injection. Plast Reconstr Surg 2014;134:917-21.
21. Kim NH, Park RH, Park JB. Botulinum toxin type A for the treatment of hypertrophy of the masseter muscle. Plast Reconstr Surg
2010;125:1693-705.
22. Matarasso A, Matarasso SL. Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg 2003;112:138S-40.
23. Filipo R, Spahiu I, Covelli E, Nicastri M, Bertoli GA. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis.
Laryngoscope 2012;122:266-70.
24. King M. Management of Ptosis. J Clin Aesthet Dermatol 2016;9:E1-4.
25. Olson JJ. Balanced botox chemodenervation of the upper face: symmetry in motion. Semin Plast Surg 2007;21:47-53.
26. Gassner HG, Brissett AE, Otley CC, et al. Botulinum toxin to improve facial wound healing: A prospective, blinded, placebo-controlled
study. Mayo Clin Proc 2006;81:1023-8.
27. Li J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol 2007;25:9-18.
28. Ghazawi FM, Zargham R, Gilardino MS, Sasseville D, Jafarian F. Insights into the pathophysiology of hypertrophic scars and keloids:
How do they differ? Adv Skin Wound Care 2018;31:582-95.
29. Kasyanju Carrero LM, Ma WW, Liu HF, Yin XF, Zhou BR. Botulinum toxin type A for the treatment and prevention of hypertrophic
scars and keloids: updated review. J Cosmet Dermatol 2019;18:10-5.
30. Xiao Z, Qu G. Effects of botulinum toxin type a on collagen deposition in hypertrophic scars. Molecules 2012;17:2169-77.
31. Austin E, Koo E, Jagdeo J. The cellular response of keloids and hypertrophic scars to Botulinum toxin A: a comprehensive literature
review. Dermatol Surg 2018;44:149-57.
32. Small R. Botulinum toxin injection for facial wrinkles. Am Fam Physician 2014;90:168-75.
33. Batniji RK, Falk AN. Update on botulinum toxin use in facial plastic and head and neck surgery. Curr Opin Otolaryngol Head Neck Surg
2004;12:317-22.
34. Naumann M, Carruthers A, Carruthers J, et al. Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®)
across multiple indications. Mov Disord 2010;25:2211-8.